- Home
- CLOV vs SANA Comparison
CLOV vs SANA Comparison
Compare CLOV & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLOV | SANA |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLOV | SANA |
|---|---|---|
| Price | $2.58 | $4.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $4.23 | ★ $7.83 |
| AVG Volume (30 Days) | 4.3M | ★ 5.9M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,773,564,000.00 | N/A |
| Revenue This Year | $41.68 | N/A |
| Revenue Next Year | $37.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.15 | N/A |
| 52 Week Low | $2.12 | $1.26 |
| 52 Week High | $4.87 | $7.30 |
Technical Indicators
Market Signals| Indicator | CLOV | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 49.11 |
| Support Level | $2.41 | $4.25 |
| Resistance Level | $2.74 | $5.05 |
| Average True Range (ATR) | 0.10 | 0.49 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 36.76 | 32.35 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.